VAKCINA

BREAKING: An influential federal advisory panel rejected a plan to offer Pfizer booster shots against COVID-19 to most Americans. The 16-2 vote was a blow to the Biden administration’s effort to increase virus protections amid the contagious delta variant. https://t.co/CFhGFfdcml

— The Associated Press (@AP) September 17, 2021

Breaking News: In a second vote, an FDA panel recommended authorizing a Pfizer booster for those 65 or older or at high risk of Covid. Earlier, the panel voted against recommending that they be authorized for everyone 16 or older.https://t.co/9bbreFu2KH

— The New York Times (@nytimes) September 17, 2021

Broj doza: 6.238.655 – prva doza 2.990.502, druga doza 2.854.142, treća doza 394.011
Državljani RS – prva doza 2.822.892, druga doza 2.705.111, treća doza 392.503
Strani državljani sa boravkom u RS – prva doza 9.939, druga doza 9.100, treća doza 595
Strani državljani bez boravka u RS – prva doza 157.671, druga doza 139.931, treća doza 913
ažurirano 16.09.2021

Broj doza: 6.089.871 – prva doza 2.960.217, druga doza 2.832.387, treća doza 297.267
Državljani RS – prva doza 2.793.709, druga doza 2.684.746, treća doza 296.152
Strani državljani sa boravkom u RS – prva doza 9.669, druga doza 8.982, treća doza 476
Strani državljani bez boravka u RS – prva doza 156.839, druga doza 138.659, treća doza 639
ažurirano 09.09.2021

3571 prva
2612 drugih
14.121 trećih
sveukupno 20.305.

China's government said that it had fully inoculated 1 billion people, 71% of the population. China has administered 2.16 billion doses, nearly triple that of India, which is ranked second for shots given and has doled out 752.7 million doseshttps://t.co/Pjvml0CbjG

— Alfons López Tena (@alfonslopeztena) September 16, 2021

While the West wages Cold War, "China has provided 1.2 billion doses of vaccines to over 100 countries, thus becoming the biggest vaccine provider in the world. We will make our due contribution to humanity’s ultimate victory over the virus." (Xi Jinping at SCO summit today)

— Carlos Martinez (@agent_of_change) September 17, 2021

Vodič za treću dozu vakcine
...
Ako ste primili dve doze Sinofarm vakcine
U Srbiji je najveći procenat stanovništva vakcinisan kineskom vakcinom Sinofarm u periodu januar-mart 2021g. Ako ste primili dve doze Sinofarm vakcine, preporuka je da se kao treća doza primi iRNK vakcina, tj. vakcina proizvođača Fajzer ili Moderna. Gornja starosna granica za primanje Fajzer vakcine ne postoji, a proveru za to imamo u zapadnim zemljama, koje su prve krenule sa vakcinisanjem najstarijih u domovima za stare.  Značajan je broj osoba u Srbiji od 90-96 godina koje su primile vakcinu Fajzer bez ikakvih nuspojava, pa je opravdano davanje ove vakcine kao treću dozu, bez obzira na to koja je bila za prve dve, kako je Nacionalni koordinacioni tim za imunizaciju u Srbiji i preporučio. Poznato je da Sinofarm vakcina daje slabiji imuni odgovor kod osoba preko 60 godina. Ta grupa ljudi razvija slabiji imunitet i nakon nekoliko meseci ga gotovo uopšte nema ili je dosta oslabio. Upravo starije osobe treba obavezno da prime treću dozu, jer je utvrđeno da čak i kod Fajzer vakcine kod 30% osoba iz grupe preko 60 godina starosti nakon šest meseci zaštita u vidu neutrališućih antitela više ne postoji. Prioritet za primanje treće doze su i pacijenti koji imaju pridružene bolesti. Ali i ostali građani, bez obzira da li su radili kontrolu antitela ili ne, treba da prime treću dozu, nakon šest meseci. Sa terena čujemo da je preporuka nekih lekara da kao treću dozu opet prime vakcinu Sinofarm, ali to nije najbolji savet, ako dve doze nisu razvile zaštitu, malo je verovatno da će treća razviti. Netačne su tvrdnje da ne valja mešati vakcine jer imamo dobre primere naučnih studija i prakse u svetu.
...

An influential Food and Drug Administration advisory committee on Friday rejected a proposal to distribute booster shots of Pfizer and BioNTech's Covid-19 vaccine to the general public, paring back those plans to unanimously recommend the third shots to people age 65 and older and other vulnerable Americans.
...
The panel voted 16-2 against distributing the vaccines to Americans 16 and older, before unanimously embracing an alternate plan to give boosters to older Americans and those at a high risk of suffering from severe illness if they get the virus. That's previously included people with diabetes, heart disease, obesity and other so-called comorbidities.

Pfizer's stock closed down 1.3%, while shares of BioNTech fell 3.6%.

The nonbinding decision by the FDA's Vaccines and Related Biological Products Advisory Committee comes as the Biden administration has said it wants to begin offering booster shots to the general public as early as next week, pending authorization from U.S. health regulators. While the agency hasn't always followed the advice of its committee, it often does. A final FDA decision could come in a matter of hours.

https://www.cnbc.com/2021/09/17/fda-panel-begins-voting-on-pfizers-covid-booster-doses-rejecting-shots-for-general-public.html

rumbeando wrote:Po dinamici vakcinacije reklo bi se da ubedljiva većina vakcinisanih u Srbiji ne namerava da uzme treću dozu.

The #malaria #vaccines will use use BioNTech's messenger #RNA technology that's already proven effective against COVID-19.#BioNTech also said it wants to produce the vaccines in #Africa, with Rwanda and Senegal as potential production locations.https://t.co/jMGo4yj0ZO

— Bill Tropical Health (@bbbrieger) September 11, 2021

https://t.co/vTcRreK8Vs

“As well as spike proteins, the new vaccine - called - currently GRT-R910 - contains other viral proteins that are less likely to evolve over time, and is also designed to induce a strong memory T-cell response.“

— Ying-PLS Doubleor use KF94orN95&🪟Fresh air (@Ying54646056) September 21, 2021